Tambagel, Baby Boy B.

HRN: 21-34-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
AMPICILLIN 250MG (VIAL)
09/13/2022
09/20/2022
IVT
138mg
Q6
AGE; T/C UTI
Waiting Final Action 
09/14/2022
CEFTRIAXONE 1G (VIAL)
09/14/2022
09/21/2022
IVF
500mg
Q24
T/C Sepsis
Waiting Final Action 
09/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2022
09/23/2022
IV
500 Mg
Q8H
AGE W MOD; T/C Sepsi
Waiting Final Action 
09/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/18/2022
09/25/2022
IV
50 Mg IVTT
7 Days
PCAP-C
Waiting Final Action 
09/24/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/24/2022
10/01/2022
IV
66 Mg Loading Dose, 33 Mg Maintenance Dose
Q24
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: